180 related articles for article (PubMed ID: 38397231)
21. Dedifferentiation in bone and soft tissue sarcomas: How do we define it? What is prognostically relevant?
Dry SM
Hum Pathol; 2024 May; 147():139-147. PubMed ID: 38311185
[TBL] [Abstract][Full Text] [Related]
22. The 'other' bone sarcomas in Japan: a retrospective study of primary bone sarcomas other than osteosarcoma, Ewing sarcoma and chondrosarcoma, using data from the Bone Tumuor Registry in Japan.
Nagano A; Tsugita M; Nishimoto Y; Akiyama H; Kawai A
Jpn J Clin Oncol; 2021 Aug; 51(9):1430-1436. PubMed ID: 34105731
[TBL] [Abstract][Full Text] [Related]
23. Small cell osteosarcoma of bone: an immunohistochemical study with differential diagnostic considerations.
Devaney K; Vinh TN; Sweet DE
Hum Pathol; 1993 Nov; 24(11):1211-25. PubMed ID: 7503935
[TBL] [Abstract][Full Text] [Related]
24. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone.
Dujardin F; Binh MB; Bouvier C; Gomez-Brouchet A; Larousserie F; Muret Ad; Louis-Brennetot C; Aurias A; Coindre JM; Guillou L; Pedeutour F; Duval H; Collin C; de Pinieux G
Mod Pathol; 2011 May; 24(5):624-37. PubMed ID: 21336260
[TBL] [Abstract][Full Text] [Related]
25. Galectin-1 (GAL-1) expression is a useful tool to differentiate between small cell osteosarcoma and Ewing sarcoma.
Machado I; López Guerrero JA; Navarro S; Mayordomo E; Scotlandi K; Picci P; Llombart-Bosch A
Virchows Arch; 2013 Jun; 462(6):665-71. PubMed ID: 23681112
[TBL] [Abstract][Full Text] [Related]
26. [Interdisciplinary diagnostic and treatment of bone sarcomas of the extremities and trunk].
Andreou D; Hardes J; Gosheger G; Henrichs MP; Nottrott M; Streitbürger A
Handchir Mikrochir Plast Chir; 2015 Apr; 47(2):90-9. PubMed ID: 25897578
[TBL] [Abstract][Full Text] [Related]
27. [Dedifferentiated chondrosarcoma: radiologic-pathologic correlation].
Bierry G; Feydy A; Larousserie F; Pluot E; Guerini H; Campagna R; Dufau-Andreu C; Anract P; Babinet A; Dietemann JL; Chevrot A; Drapé JL
J Radiol; 2010 Mar; 91(3 Pt 1):271-9. PubMed ID: 20508557
[TBL] [Abstract][Full Text] [Related]
28. Galectin-1 is a powerful marker to distinguish chondroblastic osteosarcoma and conventional chondrosarcoma.
Gomez-Brouchet A; Mourcin F; Gourraud PA; Bouvier C; De Pinieux G; Le Guelec S; Brousset P; Delisle MB; Schiff C
Hum Pathol; 2010 Sep; 41(9):1220-30. PubMed ID: 20399482
[TBL] [Abstract][Full Text] [Related]
29. Array comparative genomic hybridization reveals frequent alterations of G1/S checkpoint genes in undifferentiated pleomorphic sarcoma of bone.
Niini T; Lahti L; Michelacci F; Ninomiya S; Hattinger CM; Guled M; Böhling T; Picci P; Serra M; Knuutila S
Genes Chromosomes Cancer; 2011 May; 50(5):291-306. PubMed ID: 21254299
[TBL] [Abstract][Full Text] [Related]
30. Molecular distinction of chondrosarcoma from chondroblastic osteosarcoma through IDH1/2 mutations.
Kerr DA; Lopez HU; Deshpande V; Hornicek FJ; Duan Z; Zhang Y; Rosenberg AE; Borger DR; Nielsen GP
Am J Surg Pathol; 2013 Jun; 37(6):787-95. PubMed ID: 23598960
[TBL] [Abstract][Full Text] [Related]
31. Potential sampling error in fine needle aspiration biopsy of dedifferentiated chondrosarcoma: a report of 4 cases.
Rinas AC; Ward WG; Kilpatrick SE
Acta Cytol; 2005; 49(5):554-9. PubMed ID: 16334036
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical detection of bone morphogenetic proteins in bone and soft-tissue sarcomas.
Yoshikawa H; Rettig WJ; Lane JM; Takaoka K; Alderman E; Rup B; Rosen V; Healey JH; Huvos AG; Garin-Chesa P
Cancer; 1994 Aug; 74(3):842-7. PubMed ID: 8039112
[TBL] [Abstract][Full Text] [Related]
33. Dedifferentiated chondrosarcoma with telangiectatic osteosarcoma-like features.
Okada K; Hasegawa T; Tateishi U; Endo M; Itoi E
J Clin Pathol; 2006 Nov; 59(11):1200-2. PubMed ID: 17071806
[TBL] [Abstract][Full Text] [Related]
34. Dedifferentiated chondrosarcoma of bone with prominent rhabdoid component.
Stemm M; Beck C; Mannem R; Neilson J; Klein MJ
Ann Diagn Pathol; 2017 Jun; 28():7-11. PubMed ID: 28648942
[TBL] [Abstract][Full Text] [Related]
35. H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological features.
Makise N; Sekimizu M; Konishi E; Motoi T; Kubo T; Ikoma H; Watanabe SI; Okuma T; Hiraoka N; Fukayama M; Kawai A; Ichikawa H; Yoshida A
Mod Pathol; 2019 Mar; 32(3):435-445. PubMed ID: 30291346
[TBL] [Abstract][Full Text] [Related]
36. The clinical significance of CD44v6 in malignant and benign primary bone tumors.
Hosseini A; Eghtedari AR; Mirzaei A; Babaheidarian P; Nekoufar S; Khademian N; Jamshidi K; Tavakoli-Yaraki M
BMC Musculoskelet Disord; 2023 Jul; 24(1):607. PubMed ID: 37491225
[TBL] [Abstract][Full Text] [Related]
37. Bone and soft tissue sarcomas in cerebrospinal fluid and effusion: A 20-year review at our institution.
Sharma A; Thangaiah JJ; Shetty S; Policarpio-Nicolas MLC
Cancer Cytopathol; 2021 Oct; 129(10):776-787. PubMed ID: 34233079
[TBL] [Abstract][Full Text] [Related]
38. Subclassification of pleomorphic sarcomas: How and why should we care?
Hornick JL
Ann Diagn Pathol; 2018 Dec; 37():118-124. PubMed ID: 30340082
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis of a dedifferentiated chondrosarcoma of the pelvis by fine needle aspiration. A case report.
Estrada-Villaseñor E; Rico-Martínez G; Linares-Gonzalez LM
Acta Cytol; 2010; 54(2):217-20. PubMed ID: 20391984
[TBL] [Abstract][Full Text] [Related]
40. Pathology of primary malignant bone and cartilage tumours.
Rozeman LB; Cleton-Jansen AM; Hogendoorn PC
Int Orthop; 2006 Dec; 30(6):437-44. PubMed ID: 16944143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
